Anionic Hydrogel for Controlled Protein Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
PEG hydrogels used for biomedical applications suffer from weak mechanical properties and challenges in controlled protein release due to tight electrostatic binding of positively charged proteins, limiting their effectiveness in tissue engineering and wound healing.
Innovation Solution
Development of biocompatible and biodegradable anionic hydrogels based on poly(acrylic acid)-co-poly(oligoethylene glycol monoacrylate) using aqueous free radical polymerization, with the introduction of acrylic acid to provide negative charges and incorporation of neutral species like NIPAM to space out charge distribution, facilitating sustainable protein release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If PEG hydrogels are used for biomedical applications, then biocompatibility and non-immunogenity are achieved, but mechanical properties remain weak
Solution Approach 1:
The patent creates composite hydrogels by copolymerizing PEG-based monomers with acrylic acid and incorporating biodegradable polyester components. This composite approach combines the biocompatibility of PEG with the mechanical strength of cross-linked polyester networks, resolving the contradiction between softness and structural integrity.
2Duration of action of moving object
If PEG hydrogels are used for protein delivery, then controlled release is achieved, but protein release is limited due to tight electrostatic binding
Solution Approach 1:
The patent introduces carboxyl groups through acrylic acid copolymerization to create localized negative charges that provide mild electrostatic attraction for positively charged proteins. This local charge distribution enables controlled retention without excessive binding strength, allowing sustained yet reversible protein release.
Solution Approach 2:
The patent modifies the chemical composition parameters of the hydrogel by incorporating acrylic acid and biodegradable polyester components, which alter the electrostatic interaction parameters between the hydrogel matrix and proteins. This enables optimization of the balance between protein retention and release kinetics.
3Reliability
If acrylic acid is incorporated into PEG hydrogels, then negative charges are introduced for enhanced protein binding, but charge distribution becomes uncontrolled forming high density pockets
Solution Approach 1:
The patent uses copolymerization to distribute acrylic acid units at controlled intervals along the polymer chains, creating a uniform local charge distribution rather than random clustering. This prevents high-density charge pockets while maintaining sufficient negative charges for protein interaction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting hydrogels exhibit enhanced mechanical properties and controlled release of bioactive proteins, such as fibroblast growth factor, with increased release rates and maintained bioactivity, suitable for wound healing and regenerative medicine applications.
Implementation Method 1
electrostatic interaction(s) between the anionic hydrogels and positively charged proteins render the hydrogels capable of a sustainable release of the proteins
Implementation Method 2
Hydrogels are three-dimensional, cross-linked polymer networks that can retain a large amount of water
Data Source
AI summary
An anionic hydrogel for wound healing comprised of poly(oligoethylene glycol monoacrylate), acrylic, a neutral species and a wild-type fibroblast growth factor 1 (wtFGF1).


